Color additives used in drug products must conform to FDA regulations and be properly listed and approved for the specific use. While a qualitative or quantitative change in inactive ingredients is ...

FDA’s draft guidance outlines a flexible approach that, under certain circumstances, allows applicants and manufacturers to replace a color additive in an approved or marketed drug product with one ...

Interpretability has drawn increasing attention in machine learning. Partially linear additive models provide an attractive middle ground between the simplicity of generalized linear model and the ...

Industry groups representing drugmakers have expressed support for a US Food and Drug Administration’s (FDA) draft guidance that would make it easier to replace color additives in drugs, though they ...